Therapeutic Potential of Plant- and Marine-Derived Bioactive Compounds in Prostate Cancer: Mechanistic Insights and Translational Applications

被引:3
作者
Siddiqui, Arif Jamal [1 ]
Adnan, Mohd [1 ]
Saxena, Juhi [2 ]
Alam, Mohammad Jahoor [1 ]
Abdelgadir, Abdelmushin [1 ]
Badraoui, Riadh [1 ]
Singh, Ritu [3 ]
机构
[1] Univ Hail, Coll Sci, Dept Biol, POB 2440, Hail, Saudi Arabia
[2] Parul Univ, Parul Inst Technol, Dept Biotechnol, Vadodara 391760, Gujarat, India
[3] Cent Univ Rajasthan, Sch Earth Sci, Dept Environm Sci, Ajmer 305817, Rajasthan, India
关键词
prostate cancer; natural product; marine compounds; anticancer properties; plant-based compounds; CELL-CYCLE ARREST; GATED K+ CURRENT; NF-KAPPA-B; IN-VITRO; NATURAL-PRODUCTS; KAHALALIDE-F; RISK-FACTORS; GREEN TEA; INHIBITS PROLIFERATION; DIETARY PHYTOCHEMICALS;
D O I
10.3390/ph18030286
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
It is widely recognized that prostate cancer is a multifaceted illness that is the second most common cause of cancer-related fatalities among males. Natural sources from both plants and marine organisms have long been used in treating various diseases and in the discovery of new pharmaceutical compounds. Medicinal plants, in particular, provide bioactive substances like alkaloids, phenolic compounds, terpenes, and steroids. In addition, marine natural products play a crucial role in the search for novel cancer treatments. A substantial number of anticancer drugs have been derived from natural sources, including plants, marine organisms, and microorganisms. In fact, over the past 60 years, 80% of new chemical entities have originated from natural sources, which are generally considered safer than synthetic compounds. This review seeks to emphasize the role of phytochemical compounds derived from both plant and marine sources in prostate cancer, highlighting their potential therapeutic impact. It is also intended to support global researchers working on the identification of natural-based treatments for prostate cancer.
引用
收藏
页数:45
相关论文
共 273 条
[1]   Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines [J].
Abbas, Ata ;
Hall, J. Adam ;
Patterson, William L., III ;
Ho, Emily ;
Hsu, Anna ;
Al-Mulla, Fahd ;
Georgel, Philippe T. .
BIOCHEMISTRY AND CELL BIOLOGY, 2016, 94 (01) :71-81
[2]   Antiangiogenic drugs in combination with seaweed fucoidan: A mechanistic in vitro and in vivo study exploring the VEGF receptor and its downstream signaling molecules in hepatic cancer [J].
Abdollah, Maha R. A. ;
Ali, Aya A. ;
Elgohary, Hassnaa H. ;
Elmazar, Mohamed M. .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[3]   Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study [J].
Abedinpour, Parisa ;
Baron, Veronique T. ;
Chrastina, Adrian ;
Rondeau, Gaelle ;
Pelayo, Jennifer ;
Welsh, John ;
Borgstrom, Per .
PROSTATE, 2017, 77 (16) :1550-1562
[4]   The Anti-Cancer Effects of Frondoside A [J].
Adrian, Thomas E. ;
Collin, Peter .
MARINE DRUGS, 2018, 16 (02)
[5]   Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights [J].
Ahmed, Salman ;
Alam, Waqas ;
Jeandet, Philippe ;
Aschner, Michael ;
Alsharif, Khalaf F. ;
Saso, Luciano ;
Khan, Haroon .
MARINE DRUGS, 2022, 20 (08)
[6]   Anticancer Effects of Fucoxanthin through Cell Cycle Arrest, Apoptosis Induction, and Angiogenesis Inhibition in Triple-Negative Breast Cancer Cells [J].
Ahmed, Shade' A. ;
Mendonca, Patricia ;
Messeha, Samia S. ;
Soliman, Karam F. A. .
MOLECULES, 2023, 28 (18)
[7]   Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation [J].
Albrecht, Daniel S. ;
Clubbs, Elizabeth A. ;
Ferruzzi, Mario ;
Bomser, Joshua A. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2008, 171 (01) :89-95
[8]  
Altaf R, 2019, Journal of Cancer Prevention & Current Research, V10, DOI [10.15406/jcpcr.2019.10.00381, 10.15406/jcpcr.2019.10.00381, DOI 10.15406/JCPCR.2019.10.00381]
[9]   Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges [J].
Andreani, Tatiana ;
Cheng, Ruoyu ;
Elbadri, Khalil ;
Ferro, Claudio ;
Menezes, Thacilla ;
dos Santos, Mayara R. ;
Pereira, Carlos M. ;
Santos, Helder A. .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2024, 14 (10) :2845-2916
[10]   Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolites [J].
Asai, A ;
Sugawara, T ;
Ono, H ;
Nagao, A .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) :205-211